Haleon PLC Sponsored ADR ( (HLN) ) has issued an announcement.
On February 26, 2025, Haleon PLC announced a significant change in its shareholder structure due to Pfizer Inc.’s conversion of American depositary shares into ordinary shares. This move, involving 661,709,764 voting rights, maintains Pfizer’s 7.31% stake in Haleon, highlighting the strategic alignment between the two companies and potentially impacting Haleon’s market dynamics and investor relations.
More about Haleon PLC Sponsored ADR
Haleon PLC operates in the healthcare industry, focusing on consumer health products. The company is known for its range of over-the-counter medicines, oral health products, and vitamins, catering to a global market.
YTD Price Performance: 7.52%
Average Trading Volume: 8,878,512
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $45.34B
See more data about HLN stock on TipRanks’ Stock Analysis page.